What our partners say
AbeXXa Biologics Inc.
Jon Weidanz, CSO, talks about re-imagining cancer immunotherapy and the essential ingredients for successful partnerships.
Read more
What our partners say
Our Partners: Warren Center for Neuroscience Drug Discovery at Vanderbilt University
Craig Lindsley, Director of the WCNDD talks about the challenges facing neuroscience researchers and the commitment of Boehringer Ingelheim to this important area.
Read more
What our partners say
Our Partners: ViraTherapeutics
Lisa Egerer, COO and Patrik Erlmann, Head of Research at ViraTherapeutics talk about their partnering journey with Boehringer Ingelheim
Read more
Links
OUR PARTNERS
Our Partners: Bioharmony Therapeutics
Chandra Ghose, Founder and CEO of Bioharmony Therapeutics, talks about the urgent need for developing new antimicrobials and the benefits of partnering with Boehringer Ingelheim.
OUR PARTNERS
Our Partners: Harvard Fibrosis Network
Brock Reeve, Executive Director of the Harvard Stem Cell Institute, talks about the importance of working together to tackle the challenge of fibrosis.